Midlothian, VA — Tekton Research is proud to welcome Ben Phillips, MD, a board-certified endocrinologist and leader in diabetes, obesity, and osteoporosis care, as a Principal Investigator. This partnership expands Tekton’s clinical research footprint into the Midlothian and Richmond, Virginia region.
With over 25 years of clinical experience, Dr. Phillips brings deep expertise in treating metabolic disorders and a strong commitment to advancing patient care. Following his undergraduate studies at Vanderbilt University in Nashville, he earned his medical degree from the Medical University of South Carolina and completed his Internal Medicine residency and Endocrinology fellowship at Virginia Commonwealth University Medical Center and McGuire Veterans Hospital. He is the founder of Virginia Endocrinology, a practice with 11 physicians that will soon feature a dedicated research wing and internal diabetes education center.
Dr. Phillips is an active member of the Endocrine Society, American Association of Clinical Endocrinologists, Richmond Endocrinology Club, and the North American Association for the Study of Obesity. His clinical interests—including diabetes, obesity, metabolism, and high-risk osteoporosis—align closely with Tekton Research’s core therapeutic areas.
“I’m excited to join the Tekton Research network at this pivotal time in diabetes and obesity research,” said Dr. Phillips. “My work with high-risk osteoporosis patients has shown me the critical importance of advancing treatment options through rigorous clinical trials. Tekton’s collaborative approach and commitment to excellence aligns perfectly with my vision for patient care. As both a physician and father of four daughters, I’m passionate about research that improves long-term health outcomes for generations to come. I look forward to contributing my expertise while learning from the exceptional team at Tekton Research.”
Jeffrey Zucker, Chief Expansion Officer at Tekton Research, shared his enthusiasm:
“Dr. Phillips is a tremendous addition to our investigator network. His dedication to improving care for patients with metabolic conditions makes him an ideal partner. We’re excited to support his efforts to bring innovative clinical trials to the Midlothian and Richmond communities.”
This collaboration reinforces Tekton Research’s mission to advance clinical research in metabolic disorders and related therapeutic areas while expanding access to cutting-edge trials in new regions.